European & Developing Countries Clinical Trials Partnership (EDCTP)
نویسنده
چکیده
EDCTP was established by the European Union in 2003. The first EDCTP program ran until 2015 and focused on HIV, tuberculosis (TB) and malaria. It supported numerous clinical trials that aimed to have a significant impact on the diagnosis, treatment and prevention of these diseases. In light of significant unmet medical needs, the scope of EDCTP was extended in 2014, now covering neglected infectious diseases, diarrheal diseases, lower respiratory tract infections, and emerging and re-emerging infections affecting sub-Saharan Africa (such as Ebola virus disease and yellow fever), in addition to HIV, TB, and malaria. EDCTP has 2 offices, with its headquarter in The Hague, The Netherlands, and an African office in Cape Town, South Africa.
منابع مشابه
European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership
BACKGROUND European and Developing Countries Clinical Trials Partnership (EDCTP) was founded in 2003 by the European Parliament and Council. It is a partnership of 14 European Union (EU) member states, Norway, Switzerland, and Developing Countries, formed to fund acceleration of new clinical trial interventions to fight the human immunodeficiency virus and acquired immune deficiency syndrome (H...
متن کاملA New Vision for Clinical Trials in Africa
December 2004 | Volume 1 | Issue 3 | e71 Last year the European Parliament and Council formed the European and Developing Countries Clinical Trials Partnership (EDCTP). The aim of this new funding body, which has a budget of 400 million spread over fi ve years, is a noble one: to fund research in developing countries, particularly in Africa, that contributes to the development of affordable pro...
متن کاملBibliometric Assessment of European and Sub-Saharan African Research Output on Poverty-Related and Neglected Infectious Diseases from 2003 to 2011
BACKGROUND The European & Developing Countries Clinical Trials Partnership (EDCTP) is a partnership of European and sub-Saharan African countries that aims to accelerate the development of medical interventions against poverty-related diseases (PRDs). A bibliometric analysis was conducted to 1) measure research output from European and African researchers on PRDs, 2) describe collaboration patt...
متن کاملPanACEA: a new approach to tuberculosis research.
The completion of enrolment into the REMox TB study in January this year was an important milestone for the Pan-African Consortium for the Evaluation of Anti-Tuberculosis Antibiotics (PanACEA)—a network consisting of European research organisations, 11 sub-Saharan clinical trial sites, and three pharmaceutical companies. The trial aims to investigate the role of moxifl oxacin in reducing treatm...
متن کاملEDCTP regional networks of excellence: initial merits for planned clinical trials in Africa
BACKGROUND Achieving the Millennium Development Goals (MDGs) and combating hotspots with escalating but preventable communicable diseases remain major challenges in Africa. The European and Developing Countries Clinical Trials Partnership (EDCTP) intervened to combat poverty-related diseases including malaria, tuberculosis and HIV/AIDS, and to conduct multi-centre clinical trials and multi-disc...
متن کامل